Neutrophil-to-lymphocyte ratio in IPF patients: a novel prognostic biomarker?
. d'Alessandro (Siena, Italy), L. Bergantini (Siena, Italy), P. Cameli (Siena, Italy), A. Carleo (Hannover, Germany), P. Sestini (Siena, Italy), E. Bargagli (Siena, Italy)
Source: Virtual Congress 2020 – Prognosis and biomarkers of idiopathic pulmonary fibrosis
Disease area: Interstitial lung diseases
Rating: 
You must login to grade this presentation.
Share or cite this content
Citations should be made in the following way:
. d'Alessandro (Siena, Italy), L. Bergantini (Siena, Italy), P. Cameli (Siena, Italy), A. Carleo (Hannover, Germany), P. Sestini (Siena, Italy), E. Bargagli (Siena, Italy). Neutrophil-to-lymphocyte ratio in IPF patients: a novel prognostic biomarker?. 823
You must login to share this Presentation/Article on Twitter, Facebook, LinkedIn or by email.
Member's Comments
Related content which might interest you: